Case 2 – Trabectedin as a new opportunity in the multidisciplinary approach to the advanced ovarian cancer: report of a long-term survival case

Abstract

We present a particular and explicative case of long-term survival bilateral ovarian cancer, heavily pre-treated, in which disease stabilization was achieve with the use of pegylated liposomal doxorubicin and trabectedin. This case is also of interest in that it investigates the benefit of cytoreductive and palliative surgery for bowel obstruction in the second or subsequent relapse in epithelial ovarian cancer. Our experience shows that the multidisciplinary treatment modality in these complex cases – combining both medical and surgical modalities – also involving new agents, such as trabectedin, should ensure a consistent and equitable approach to planning and managing care for advanced ovarian cancer in order to offer each of our patients the best strategy for improving survival and quality of life.